spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SMi presents the 13th Conference on ADMET

SMi presents the 13th Conference on ADMET

9-10 July 2018
Holiday Inn Kensington Forum, London, UK

SMi is delighted to announce the 13th annual ADMET conference returning to London on the 9th - 10th July 2018, featuring.

Developments in ADMET and novel technologies determine the properties of a drug candidate in the preclinical stage of drug discovery. Poor ADMET properties are the principal cause for a candidate to fail at any stage of drug development. ADME-Toxicology and Pharmacokinetic studies are the key strategic check-points for pharmaceutical companies to reduce drug discovery cost and minimise production times.

The growing use of ADMET technologies is driving the market growth, which is estimated to reach $14,319.9 Million by 2022, with a CAGR of 10.6% from 2016 to 2022*. The main objective of early prediction of ADME properties of a compound is to increase the success rate of it reaching the development stage.

*Source: http://bit.ly/2hMJcgU

Who should attend?

  • DMPK Professionals 
  • Pharmacologists 
  • Computational Scientists 
  • Medicinal Chemists 
  • Statisticians 
  • Principle scientist 
  • Drug Metabolism Experts 
  • ADME Toxicologists 
  • Research fellows 
  • PK/PD modelling 
  • Toxicologist 
  • Anatomists 

Join our expert speaker panels at the ADMET conference to ensure you do not miss out on the latest developments!

Presenting new technologies, specific case studies and PK modelling strategies in the areas of DMPK, PBPK, PKPD, in vitro/ex vivo/in vivo/in silico, biologics, transporters, hazard and safety assessments, ADMET modelling, and many more.

This event is CPD accredited.

#SMiADMET

phone +44 (0)20 7827 6000
email events@smi-online.co.uk
web bit.ly/2JnTMVZ
email Holiday Inn Kensington Forum, London, UK
 
Print this page
Send to a friend
   
spacer
Industry Events

Clinical Innovation Partnerships 2018

3-4 July 2018, Radisson Blu Hotel, Zurich Airport

Clinical Innovation Partnerships is the only event for senior clinical operations and procurement professionals driving innovation in their clinical trials. It is where the pharma, CRO and vendor clinical trials ecosystem meet to drive innovation in digitalisation, tech and partnering to improve patient experience and reduce trial cost and time.
More info >>

Banner of T3_events_97 on Samedan

White Papers

Case Study: Amber™, featuring Pushclick Technology

SHL Group

The Amber™ Auto Injector is a single-dose, disposable auto injector with a unique patient-centric industrial design. This device features Pushclick™ technology, which enables it to be activated by simply pushing against the injection site, a total of only 2 simple steps. The unique ergonomic industrial design of the device provides various grip options when removing the cap and when performing the injection. Safety features and essential audible, visual and tactile feedback mechanisms are also integrated into the device.
More info >>


News and Press Releases

Mologic Signs Agreements with Medisur and Peripal to Distribute PERiPLEX POC Diagnostic in Europe

Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®, a rapid point-of-care (POC) test for the detection of infection in patients on peritoneal dialysis (PD). Both companies are specialists in the development and distribution of products which enable patient self-management and will supply PERiPLEX as part of a highly complementary product portfolio in key European markets including France, Germany, Italy, The Netherlands, Austria and Switzerland.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement